130946-73-5

Basic information

• Product Name: Acetic acid, (4-chlorophenoxy)-, 2-(dithiocarboxy)hydrazide, monopotassium salt
• CAS NO: 130946-73-5
• Molecular Formula: C9H9ClN2O2S2.K
• Molecular Weight: 314.858
• Mol File: 130946-73-5.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: Acetic acid, (4-chlorophenoxy)-, 2-(dithiocarboxy)hydrazide, monopotassium salt(CAS DataBase Reference)
• NIST Chemistry Reference: Acetic acid, (4-chlorophenoxy)-, 2-(dithiocarboxy)hydrazide, monopotassium salt(130946-73-5)
• EPA Substance Registry System: Acetic acid, (4-chlorophenoxy)-, 2-(dithiocarboxy)hydrazide, monopotassium salt(130946-73-5)

Safety Data

• Hazardous Substances Data: 130946-73-5(Hazardous Substances Data)

Upstream product

• 14426-42-7 ethyl p-chlorophenoxyacetate 
• 122-88-3 4-Chlorophenoxyacetic acid 
• 75-15-0 carbon disulfide 
• 2381-75-1 (4-chlorophenoxy)acetic acid hydrazide 
• 106-48-9 4-chloro-phenol 

Downstream Products

• 118794-65-3 3-(4-Chloro-phenoxymethyl)-6-(5-nitro-furan-2-yl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine 
• 14758-91-9 5-(4-Chloro-phenoxymethyl)-4-{[1-(5-nitro-furan-2-yl)-meth-(E)-ylidene]-amino}-4H-[1,2,4]triazole-3-thiol 
• 155776-80-0 4-Bromo-4-[5-(4-chloro-phenoxymethyl)-4-phenylamino-4H-[1,2,4]triazol-3-ylsulfanyl]-2,5-diphenyl-2,4-dihydro-pyrazol-3-one 
• 155776-44-6 4-[5-(4-Chloro-phenoxymethyl)-4-phenylamino-4H-[1,2,4]triazol-3-ylsulfanyl]-2,5-diphenyl-2,4-dihydro-pyrazol-3-one 
• 155776-62-8 4-Bromo-4-[5-(4-chloro-phenoxymethyl)-4-phenylamino-4H-[1,2,4]triazol-3-ylsulfanyl]-5-methyl-2-phenyl-2,4-dihydro-pyrazol-3-one 
• 155776-71-9 4-Bromo-4-[5-(4-chloro-phenoxymethyl)-4-phenylamino-4H-[1,2,4]triazol-3-ylsulfanyl]-5-phenyl-2,4-dihydro-pyrazol-3-one 
• 155776-26-4 4-[5-(4-Chloro-phenoxymethyl)-4-phenylamino-4H-[1,2,4]triazol-3-ylsulfanyl]-5-methyl-2-phenyl-2,4-dihydro-pyrazol-3-one 
• 155777-34-7 5-Bromo-5-[5-(4-chloro-phenoxymethyl)-4-phenylamino-4H-[1,2,4]triazol-3-ylsulfanyl]-pyrimidine-2,4,6-trione 
• 155776-35-5 4-[5-(4-Chloro-phenoxymethyl)-4-phenylamino-4H-[1,2,4]triazol-3-ylsulfanyl]-5-phenyl-2,4-dihydro-pyrazol-3-one 
• 155777-25-6 5-[5-(4-Chloro-phenoxymethyl)-4-phenylamino-4H-[1,2,4]triazol-3-ylsulfanyl]-pyrimidine-2,4,6-trione 
• 155776-53-7 4-Bromo-4-[5-(4-chloro-phenoxymethyl)-4-phenylamino-4H-[1,2,4]triazol-3-ylsulfanyl]-5-methyl-2,4-dihydro-pyrazol-3-one 
• 155776-17-3 4-[5-(4-Chloro-phenoxymethyl)-4-phenylamino-4H-[1,2,4]triazol-3-ylsulfanyl]-5-methyl-2,4-dihydro-pyrazol-3-one 

Relevant articles and documents

Expedient discovery for novel antifungal leads: 1,3,4-Oxadiazole derivatives bearing a quinazolin-4(3H)-one fragment

Developing novel fungicide candidates are intensively promoted by the rapid emergences of resistant fungi that outbreak on agricultural production. Aiming to discovery novel antifungal leads, a series of 1,3,4-oxadiazole derivatives bearing a quinazolin-4(3H)-one fragment were constructed for evaluating their inhibition effects against phytopathogenic fungi in vitro and in vivo. Systematically structural optimizations generated the bioactive molecule I32 that was identified as a promising inhibitor against Rhizoctonia solani with the in vivo preventative effect of 58.63% at 200 μg/mL. The observations that were captured by scanning electron microscopy and transmission electron microscopy demonstrated that the bioactive molecule I32 could induce the sprawling growth of hyphae, the local shrinkage and rupture on hyphal surfaces, the extreme swelling of vacuoles, the striking distortions on cell walls, and the reduction of mitochondria numbers. The above results provided an indispensable complement for the discovery of antifungal lead bearing a quinazolin-4(3H)-one and 1,3,4-oxadiazole fragment.

Polyethylene glycol mediated, one-pot, three-component synthetic protocol for novel 3-[3-substituted-5-mercapto-1,2,4-triazol-4-yl]-spiro-(indan-1′,2-thiazolidin)-4-ones as new class of potential antimicrobial and antitubercular agents

A series of 3-[3-substituted-5-mercapto-1,2,4-triazol-4-yl]-spiro-(indan-1′,2-thiazolidin)-4-ones 2 were designed for the purpose of searching for novel antimicrobial agents and have been synthesized conveniently in a single step with a three-component protocol in polyethylene (400) as green reaction media. Thus, the condensation reaction between indane-1-one; 4-amino-5-mercapto-1,2,4-triazoles and mercaptoacetic acid in polyethylene glycol (400) gave quantitatively and analytically pure titled compounds 2. The structure of synthesized compound 2 is based on spectral (IR, 1H-NMR, and 13C-NMR) as well elemental analyses. These compounds have been screened for their antibacterial, antifungal, and antitubercular activities. Some of them have showed significant inhibition on fungal and bacterial growth and antitubercular activity against Mycobacterium tuberculosis. The compounds 2a, 2d, and 2e display antifungal activity against Candida albicans [minimum inhibitory concentration (MIC) 3.13, 6.25 μg/mL] and antibacterial activity against Streptococcus pneumoniae (MIC 3.13 μg/mL) of the order of standard drugs tested under similar conditions, and compound 2a showed better antitubercular activity than other compounds against M. tuberculosis (H37Rv strain, MIC 12.5 μg/mL).

Investigation on the reaction of 4-anilino-5-mercapto-s-triazoles with pyrazolines and barbituric acids

Synthesis of new 4-anilino-5-mercapto-3-substituted-1,2,4-triazoles (III) has been described.Reaction of III with 4,4-dibromo-substituted-pyrazolin-5-ones (VIII) affords 3,3'-substituted-5-phenyl-s-triazolothiadiazolidin-spiropyrazolin-5-ones